Green Roads of Florida LLC FDA Warning (2017)
Compiled by the Supplement Safety Data Team | Sourced from Official FDA Records on October 31, 2017
Executive Summary
The FDA issued a warning letter to Green Roads of Florida LLC on October 31, 2017 citing regulatory violations. Consumers who have purchased products from this company should exercise caution. The letter was issued by San Juan District Office.
Detailed Analysis
False Claims and Regulatory Violations
“Almost all studies recognize CBD’s potential in preventing both cancer spread and growth…”
“The following are some of the many ailments CBD oil can potentially be therapeutic for: asthma, Alzheimer’s disease, arthritis, autism, bipolar disorder, various types of cancer . . .”
“…considering the lack of risks associated with CBD it is an attractive alternative or addition to anyone’s treatment for Alzheimer’s disease.”
Potential Health Risks
Consumers should be aware of potential risks associated with products from Green Roads of Florida LLC.
Regulatory Context
This warning letter is part of the FDA's enforcement of federal regulations.
Key Entities Identified
Frequently Asked Questions
- What did the FDA find wrong with Green Roads of Florida LLC?
- The FDA issued a warning letter citing regulatory violations related to their products or manufacturing practices.
- Are Green Roads of Florida LLC products safe to use?
- Based on the FDA's findings, consumers should exercise caution. The company was found to have regulatory issues that may affect product safety.
- What should I do if I've used Green Roads of Florida LLC products?
- If you have used products from Green Roads of Florida LLC and experience any adverse effects, contact your healthcare provider immediately. You can also report adverse events to the FDA's MedWatch program.
Source Document
This report is based on an official FDA warning letter. The original document is a public record.
View Original FDA Warning Letter